Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Montserrat Business Network.
Press releases published on August 4, 2025
Alligator Alcatraz: U.S. Politics Today Report Probes Florida’s Controversial Immigration Site
EIN Presswire
·
August 4, 2025
USPT interviews state Sen. Shevrin Jones about his visit to the remote detention center WASHINGTON , DC, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- U.S. Politics Today (USPT), an independent Substack publication offering European-informed …
Graphjet visited by Korean company
GlobeNewswire
·
August 4, 2025
New York, United States, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Graphjet Technology (the “Company”) was honoured to receive the visit of management executives of a leading South Korean conglomerate, well-regarded globally in the steel and battery materials …
ALGN ALERT: Investigation Launched into Align Technology, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact RGRD Law
GlobeNewswire
·
August 4, 2025
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman …
W&T Offshore Announces Second Quarter 2025 Results, Declares Dividend for Third Quarter of 2025 and Celebrates 20 Year Anniversary on New York Stock Exchange
GlobeNewswire
·
August 4, 2025
HOUSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- W…
Artesian Resources Corporation Reports Second Quarter and Year-To-Date 2025 Results
GlobeNewswire
·
August 4, 2025
NEWARK, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider on the Delmarva Peninsula of water and wastewater services, and a number of other related business services, today announced second quarter …
Cabot Corp Reports Third Quarter Fiscal 2025 Results
GlobeNewswire
·
August 4, 2025
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced results for its third quarter of fiscal year 2025. Q3 FY25 Key Highlights Diluted EPS of $1.86 and Adjusted EPS of $1.90, which represents a 1% decrease in Adjusted EPS …
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 4, 2025
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it issued grants of employment inducement awards to Anshul Thakral, the Company’s recently …
Cabot Corporation to Acquire Mexico Carbon Manufacturing S.A. de C.V. from Bridgestone Corporation
GlobeNewswire
·
August 4, 2025
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) announced that it has entered into a definitive agreement to acquire Mexico Carbon Manufacturing S.A. de C.V. (MXCB) from Bridgestone Corporation. The reinforcing carbons manufacturing …
INNOVATE Closes Indebtedness Refinancing Transactions
GlobeNewswire
·
August 4, 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend …
Rubico Announces Commencement of Trading on the Nasdaq Capital Market
GlobeNewswire
·
August 4, 2025
ATHENS, Greece, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Rubico Inc. (the “Company” or “Rubico”) (Nasdaq: RUBI) announced today that it has completed its spin-off from Tops Ships Inc. effective August 1, 2025. The Company’s shares have commenced trading as of …
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 4, 2025
MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 4, 2025
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Bit Origin Announces Completion of Share Capital Reduction
GlobeNewswire
·
August 4, 2025
SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company") today announced that it has completed a reduction of its issued share capital, following the approval by its shareholders and subsequent confirmation …
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
GlobeNewswire
·
August 4, 2025
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in …
Stride, Inc. Signs Multi-District Agreements to Operate K12-Powered Online School in New Mexico
GlobeNewswire
·
August 4, 2025
RESTON, VA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Stride, Inc. (NYSE: LRN) has now partnered with Chama Valley Independent Schools and Santa Rosa Consolidated Schools, to operate Destinations Career Academy of New Mexico (NMDCA), one of its K12-powered online …
Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference
GlobeNewswire
·
August 4, 2025
NOVI, Mich., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
GlobeNewswire
·
August 4, 2025
LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …
Unitil Reports Second Quarter Earnings
GlobeNewswire
·
August 4, 2025
HAMPTON, N.H., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) today announced Net Income of $4.0 million, or $0.25 in Earnings Per Share (EPS) for the second quarter of 2025, a decrease of $0.3 million in Net Income, or $0.02 …
LM Funding America Announces Second Quarter 2025 Earnings Call for August 14, 2025
GlobeNewswire
·
August 4, 2025
TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin mining and technology-based specialty finance company, today announced that it has scheduled its second quarter 2025 earnings …
Mercado Libre Delivers Another Strong Performance in Q2'25, Reporting $6.8 billion Revenue and $825 million Income from Operations
GlobeNewswire
·
August 4, 2025
Montevideo, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mercado Libre Delivers Another Strong Performance in Q2'25, reporting $6.8 billion revenue and $825 million income from operations In Commerce, items sold rose 31% YoY driven by the fastest pace of growth in …